# OLE Study With Filgotinib in JIA

> **NCT07553182** · PHASE3 · RECRUITING · sponsor: **Alfasigma S.p.A.** · enrollment: 80 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis (JIA)

## Interventions

- **DRUG:** Filgotinib

## Key facts

- **NCT ID:** NCT07553182
- **Lead sponsor:** Alfasigma S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553182, "OLE Study With Filgotinib in JIA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07553182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*